BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 23241652)

  • 1. Modulation of miR‑122 expression affects the interferon response in human hepatoma cells.
    Li A; Qian J; He J; Zhang Q; Zhai A; Song W; Li Y; Ling H; Zhong Z; Zhang F
    Mol Med Rep; 2013 Feb; 7(2):585-90. PubMed ID: 23241652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the antitumor effects of interferon-alpha and beta on human hepatocellular carcinoma cell lines.
    Murata M; Nabeshima S; Kikuchi K; Yamaji K; Furusyo N; Hayashi J
    Cytokine; 2006 Feb; 33(3):121-8. PubMed ID: 16522372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclooxygenase-2 inhibitor and interferon-beta synergistically induce apoptosis in human hepatoma cells in vitro and in vivo.
    Nakamoto N; Higuchi H; Kanamori H; Kurita S; Tada S; Takaishi H; Toda K; Yamada T; Kumagai N; Saito H; Hibi T
    Int J Oncol; 2006 Sep; 29(3):625-35. PubMed ID: 16865278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased miR122 in hepatocellular carcinoma leads to chemoresistance with increased arginine.
    Kishikawa T; Otsuka M; Tan PS; Ohno M; Sun X; Yoshikawa T; Shibata C; Takata A; Kojima K; Takehana K; Ohishi M; Ota S; Noyama T; Kondo Y; Sato M; Soga T; Hoshida Y; Koike K
    Oncotarget; 2015 Apr; 6(10):8339-52. PubMed ID: 25826076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression level of Bcl-XL critically affects sensitivity of hepatocellular carcinoma cells to LIGHT-enhanced and interferon-gamma-induced apoptosis.
    Li J; Shen F; Wu D; Wei LX; Wang YZ; Shi LH; Zou Y; Wu MC
    Oncol Rep; 2007 May; 17(5):1067-75. PubMed ID: 17390046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stronger growth-inhibitory effect of interferon (IFN)-beta compared to IFN-alpha is mediated by IFN signaling pathway in hepatocellular carcinoma cells.
    Damdinsuren B; Nagano H; Wada H; Kondo M; Ota H; Nakamura M; Noda T; Natsag J; Yamamoto H; Doki Y; Umeshita K; Dono K; Nakamori S; Sakon M; Monden M
    Int J Oncol; 2007 Jan; 30(1):201-8. PubMed ID: 17143530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The up-regulation of type I interferon receptor gene plays a key role in hepatocellular carcinoma cells in the synergistic antiproliferative effect by 5-fluorouracil and interferon-alpha.
    Oie S; Ono M; Yano H; Maruyama Y; Terada T; Yamada Y; Ueno T; Kojiro M; Hirano K; Kuwano M
    Int J Oncol; 2006 Dec; 29(6):1469-78. PubMed ID: 17088986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant adenoviral vectors turn on the type I interferon system without inhibition of transgene expression and viral replication.
    Huarte E; Larrea E; Hernández-Alcoceba R; Alfaro C; Murillo O; Arina A; Tirapu I; Azpilicueta A; Hervás-Stubbs S; Bortolanza S; Pérez-Gracia JL; Civeira MP; Prieto J; Riezu-Boj JI; Melero I
    Mol Ther; 2006 Jul; 14(1):129-38. PubMed ID: 16627004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-122 sensitizes HCC cancer cells to adriamycin and vincristine through modulating expression of MDR and inducing cell cycle arrest.
    Xu Y; Xia F; Ma L; Shan J; Shen J; Yang Z; Liu J; Cui Y; Bian X; Bie P; Qian C
    Cancer Lett; 2011 Nov; 310(2):160-9. PubMed ID: 21802841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the Fas/FasL pathway in combination therapy with interferon-alpha and fluorouracil against hepatocellular carcinoma in vitro.
    Nakamura M; Nagano H; Sakon M; Yamamoto T; Ota H; Wada H; Damdinsuren B; Noda T; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Nakamori S; Dono K; Monden M
    J Hepatol; 2007 Jan; 46(1):77-88. PubMed ID: 17045692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-146a suppresses the sensitivity to interferon-α in hepatocellular carcinoma cells.
    Tomokuni A; Eguchi H; Tomimaru Y; Wada H; Kawamoto K; Kobayashi S; Marubashi S; Tanemura M; Nagano H; Mori M; Doki Y
    Biochem Biophys Res Commun; 2011 Nov; 414(4):675-80. PubMed ID: 21982769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-alpha sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-kappa B inactivation.
    Shigeno M; Nakao K; Ichikawa T; Suzuki K; Kawakami A; Abiru S; Miyazoe S; Nakagawa Y; Ishikawa H; Hamasaki K; Nakata K; Ishii N; Eguchi K
    Oncogene; 2003 Mar; 22(11):1653-62. PubMed ID: 12642868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different tumoricidal effects of interferon subclasses and p53 status on hepatocellular carcinoma development and neovascularization.
    Noguchi R; Yoshiji H; Ikenaka Y; Kitade M; Kaji K; Yoshi J; Yanase K; Namisaki T; Yamazaki M; Tsujimoto T; Akahane T; Uemura M; Fukui H
    Int J Oncol; 2008 Jan; 32(1):193-9. PubMed ID: 18097559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-alpha delays S-phase progression in human hepatocellular carcinoma cells via inhibition of specific cyclin-dependent kinases.
    Murphy D; Detjen KM; Welzel M; Wiedenmann B; Rosewicz S
    Hepatology; 2001 Feb; 33(2):346-56. PubMed ID: 11172336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-alpha/beta upregulate IL-15 expression in vitro and in vivo: analysis in human hepatocellular carcinoma cell lines and in chronic hepatitis C patients during interferon-alpha/beta treatment.
    Yamaji K; Nabeshima S; Murata M; Chong Y; Furusyo N; Ikematsu H; Hayashi J
    Cancer Immunol Immunother; 2006 Apr; 55(4):394-403. PubMed ID: 16041541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of IFN-alpha and 5-fluorouracil induces apoptosis through IFN-alpha/beta receptor in human hepatocellular carcinoma cells.
    Kondo M; Nagano H; Wada H; Damdinsuren B; Yamamoto H; Hiraoka N; Eguchi H; Miyamoto A; Yamamoto T; Ota H; Nakamura M; Marubashi S; Dono K; Umeshita K; Nakamori S; Sakon M; Monden M
    Clin Cancer Res; 2005 Feb; 11(3):1277-86. PubMed ID: 15709199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium butyrate enhances STAT 1 expression in PLC/PRF/5 hepatoma cells and augments their responsiveness to interferon-alpha.
    Hung WC; Chuang LY
    Br J Cancer; 1999 May; 80(5-6):705-10. PubMed ID: 10360647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interferon-alpha upregulates thymidine phosphorylase expression via JAK-STAT transcriptional activation and mRNA stabilization in human hepatocellular carcinoma SMMC-7721 cells].
    Xiao YS; Zhou J; Fan J; Sun QM; Zhao Y; Sun RX; Liu YK; Tang ZY
    Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):444-7. PubMed ID: 19024520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-tumor effects of various interferons-alpha +5-fluorouracil via downregulation of dihydropyrimidine dehydrogenase in hepatoma cells].
    Fan XY; Uchida H; Iwaki K; Kai S; Shibata K; Ohta M; Kitano S
    Gan To Kagaku Ryoho; 2007 Jun; 34(6):957-9. PubMed ID: 17565266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of the effects of interferon a on several human hepatoma cell lines: analysis of the signalling pathway of the cytokine and of its effects on apoptosis and cell proliferation.
    Legrand A; Vadrot N; Lardeux B; Bringuier AF; Guillot R; Feldmann G
    Liver Int; 2004 Apr; 24(2):149-60. PubMed ID: 15078480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.